These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21172105)

  • 81. Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review.
    Kith G; Lisker S; Sarkar U; Barr-Walker J; Breyer BN; Palmer NR
    Eur Urol Oncol; 2021 Apr; 4(2):192-201. PubMed ID: 31288992
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.
    An JY; Sidana A; Choyke PL; Wood BJ; Pinto PA; Türkbey İB
    Balkan Med J; 2017 Sep; 34(5):388-396. PubMed ID: 28990929
    [TBL] [Abstract][Full Text] [Related]  

  • 83. How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.
    Loeb S; Walter D; Curnyn C; Gold HT; Lepor H; Makarov DV
    J Urol; 2016 Sep; 196(3):721-6. PubMed ID: 26946161
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Five-year nationwide follow-up study of active surveillance for prostate cancer.
    Loeb S; Folkvaljon Y; Makarov DV; Bratt O; Bill-Axelson A; Stattin P
    Eur Urol; 2015 Feb; 67(2):233-8. PubMed ID: 24993868
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan.
    Koizumi C; Suetomi T; Matsuoka T; Ikeda A; Kimura T; Onozawa M; Miyazaki J; Kawai K; Takahashi H; Akaza H; Nishiyama H
    Prostate Int; 2014 Mar; 2(1):19-25. PubMed ID: 24693530
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience.
    Soloway MS; Soloway CT; Williams S; Ayyathurai R; Kava B; Manoharan M
    BJU Int; 2008 Jan; 101(2):165-9. PubMed ID: 17850361
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interval from prostate biopsy to radical prostatectomy: effect on PSA, Gleason sum, and risk of recurrence.
    Shibata A; Mohanasundaram UM; Terris MK
    Urology; 2005 Oct; 66(4):808-13. PubMed ID: 16230143
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics.
    Krakowsky Y; Loblaw A; Klotz L
    J Urol; 2010 Jul; 184(1):131-5. PubMed ID: 20478589
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?
    Ploussard G; Salomon L; Xylinas E; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A
    J Urol; 2010 Feb; 183(2):539-44. PubMed ID: 20006888
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Active surveillance for prostate cancer in a veteran population.
    Lee EK; Baack J; Penn H; Bromfield CT; Duchene DA; Thrasher JB; Holzbeierlein JM
    Can J Urol; 2010 Dec; 17(6):5429-35. PubMed ID: 21172105
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Active surveillance: pitfalls to consider.
    Ercole B; Parekh DJ
    Arch Esp Urol; 2011 Oct; 64(8):695-702. PubMed ID: 22052752
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Implementation of PSA-based active surveillance in prostate cancer.
    Jalloh M; Cooperberg MR
    Biomark Med; 2014; 8(5):747-53. PubMed ID: 25123041
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Innovations in prostate biopsy strategies for active surveillance and focal therapy.
    Ukimura O; Hung AJ; Gill IS
    Curr Opin Urol; 2011 Mar; 21(2):115-20. PubMed ID: 21178631
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Active surveillance of prostatic cancer].
    Vasarainen H; Ruutu M; Rannikko A
    Duodecim; 2011; 127(6):593-9. PubMed ID: 21528523
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.